Depends on the price elasticity of demand. If you widen the access to the thing by lowering the price, it’s possible that you might make more profit than someone who has fewer customers who they make a lot more profit per customer off of.
Setting a price isn’t necessarily a decision made with respects to the interests of one company. Not knowing precisely how the marketing groups for medical goods in the US are set up, beyond that they’re pretty abusive, I don’t care to argue that one way or the other though.
Depends on the price elasticity of demand. If you widen the access to the thing by lowering the price, it’s possible that you might make more profit than someone who has fewer customers who they make a lot more profit per customer off of.
In situations where this is the case, the company in question doesn’t need to be ordered by the government to do this.
Setting a price isn’t necessarily a decision made with respects to the interests of one company. Not knowing precisely how the marketing groups for medical goods in the US are set up, beyond that they’re pretty abusive, I don’t care to argue that one way or the other though.